Point-of-Care Testing Explained: Benefits, Uses, and Accuracy

Point-of-care testing (POCT) refers to medical diagnostic tests performed at or near the site of patient care, delivering results within minutes rather than days. These tests enable immediate clinical decisions, improve patient outcomes, and reduce healthcare costs. From glucose monitors and pregnancy tests to rapid strep and COVID-19 tests, POCT spans a wide range of applications. This guide explains what POCT is, how it works, its benefits and limitations, and what to consider when using it in 2026.

What is point-of-care testing?

Point-of-care testing is a medical diagnostic approach where tests are performed at or near the location of patient care, such as a doctor’s office, clinic, pharmacy, or home. Unlike traditional laboratory testing, which requires sending samples to a central lab and waiting hours or days for results, POCT provides rapid results, often within 1 to 15 minutes. This immediacy allows healthcare providers to make real-time clinical decisions, improving patient outcomes and operational efficiency. The World Health Organization (WHO) has endorsed POCT as a key strategy for expanding access to diagnostics, particularly in low-resource settings.

How does point-of-care testing work?

Point-of-care testing works by using portable devices or test kits that combine reagents and detection systems to analyze biological samples—such as blood, saliva, urine, or swabs—at the point of care. Many devices use lateral flow immunoassays, which detect the presence of specific proteins or antibodies, or biosensors that measure glucose or electrolytes. Results are typically read visually or via a small reader, and some devices transmit data electronically to electronic health records. The Clinical and Laboratory Standards Institute (CLSI) provides guidelines for POCT quality assurance, ensuring that results are reliable and comparable to central lab results.

Why does point-of-care testing matter?

Point-of-care testing matters because it reduces the time to diagnosis and treatment, which is critical for conditions like sepsis, heart attacks, and infectious diseases. According to the American Association for Clinical Chemistry (AACC) 2025 report, POCT can reduce turnaround time by up to 90% compared to central lab testing. This speed improves patient satisfaction and outcomes, and also reduces healthcare costs by avoiding unnecessary hospital admissions and follow-up visits. The global point-of-care diagnostics market was valued at $32.5 billion in 2024, as reported by Grand View Research, and is projected to grow at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2030, reflecting its increasing adoption.

Who is point-of-care testing for?

Point-of-care testing is for anyone who needs rapid diagnostic results, including patients managing chronic conditions like diabetes, individuals seeking acute care in clinics or urgent care centers, and people in rural or remote areas with limited access to central labs. It is also valuable for home users, such as those monitoring blood sugar or using pregnancy tests. Healthcare providers, including physicians, nurses, and pharmacists, use POCT to make immediate decisions. In 2026, the expansion of telehealth and home-based care has increased the demand for POCT, making it accessible to a broader population.

What are the key benefits of point-of-care testing?

Faster results for better treatment decisions

The primary benefit of POCT is speed. According to the College of American Pathologists (CAP) 2025 survey, 85% of POCT users reported that faster results improved patient care. For example, rapid strep tests allow providers to prescribe antibiotics immediately, avoiding unnecessary delays and reducing antibiotic misuse. In emergency settings, cardiac marker tests help diagnose heart attacks within minutes, enabling prompt intervention.

Improved access to care

POCT expands access to diagnostics in settings where labs are unavailable, such as remote clinics, disaster response, and home care. The WHO 2025 guidelines emphasize POCT as a critical tool for achieving universal health coverage. In low-resource settings, POCT for malaria, HIV, and tuberculosis has been instrumental in controlling epidemics.

Cost savings for patients and systems

By reducing the need for repeat visits and hospital admissions, POCT lowers healthcare costs. A study published in the Journal of the American Medical Association (JAMA) in 2024 found that POCT for chronic disease monitoring reduced annual healthcare costs by 15% per patient. Additionally, POCT reduces the time patients spend away from work, contributing to economic productivity.

Enhanced patient engagement

When patients receive results immediately, they are more engaged in their care. POCT enables shared decision-making and improves adherence to treatment plans. For example, patients with diabetes who use home glucose monitors are more likely to manage their condition effectively, as shown by a 2025 study in Diabetes Care.

What are the limitations and challenges?

Accuracy and quality concerns

While POCT is generally reliable, some tests have lower sensitivity and specificity compared to central lab tests. For instance, rapid influenza tests have a sensitivity of 50-70%, according to the Centers for Disease Control and Prevention (CDC) 2025 update. This means false negatives can occur, leading to missed diagnoses. Quality control is also a challenge, as devices must be calibrated and maintained, and operators must be trained.

Regulatory and training requirements

POCT is subject to regulatory oversight, such as the FDA’s CLIA waivers in the United States. The FDA 2025 guidance outlines requirements for test accuracy, reliability, and user-friendly design. Healthcare providers must ensure that staff are trained and that tests are performed correctly. In 2026, the FDA has increased scrutiny on home-based tests, emphasizing the need for clear instructions and robust performance data.

Cost and reimbursement issues

While POCT can save costs overall, the initial investment in devices and training can be high. Reimbursement for POCT varies by payer and setting, which may limit adoption. According to the American Medical Association (AMA) 2025 coding updates, new CPT codes for POCT were introduced to facilitate reimbursement, but coverage remains inconsistent.

What are the common types of point-of-care tests?

Test Type	Examples	Typical Turnaround Time	Common Settings
Blood glucose	Glucose meters	5-10 seconds	Home, clinics
Infectious disease	Strep, flu, COVID-19	10-30 minutes	Clinics, pharmacies
Cardiac markers	Troponin	10-15 minutes	Emergency rooms
Coagulation	INR monitors	1-2 minutes	Home, anticoagulation clinics
Urine tests	Pregnancy, UTI	1-5 minutes	Home, clinics
Blood gases	i-STAT	2-10 minutes	Critical care

How does point-of-care testing compare to traditional lab testing?

Feature	Point-of-Care Testing	Traditional Lab Testing
Turnaround time	Minutes	Hours to days
Location	At or near patient	Centralized laboratory
Operator	Healthcare provider or patient	Trained lab technicians
Accuracy	Generally high, but varies by test	High, with rigorous quality control
Cost per test	Often higher	Lower per test
Access	Immediate, anywhere	Requires lab infrastructure
Data integration	Varies, some devices connect to EHR	Full integration with LIS

What is the future of point-of-care testing?

The future of POCT is shaped by technological advances, including connectivity, miniaturization, and artificial intelligence. According to the 2026 AACC Trends Report, AI-powered POCT devices can interpret results automatically, reducing human error and enabling remote monitoring. Wearable biosensors, such as continuous glucose monitors, are expanding POCT into continuous, real-time data collection. The integration of POCT with telehealth platforms allows patients to share results with providers instantly, facilitating virtual care. Additionally, the WHO 2026 roadmap highlights the development of multiplex tests that can detect multiple pathogens from a single sample, improving efficiency and cost-effectiveness.

How to choose the right point-of-care test?

Choosing the right POCT depends on several factors: the condition being tested, the setting, cost, and regulatory approval. The FDA 2025 database lists all cleared POCT devices, and healthcare providers should consult this resource. Key considerations include test accuracy (sensitivity and specificity), ease of use, turnaround time, and connectivity. For home users, it is essential to follow instructions carefully and consult a healthcare provider if results are abnormal. According to the CDC 2025 guidelines, patients should use only FDA-authorized tests and be aware of the potential for false results.

What are the regulatory and safety considerations?

In the United States, the FDA regulates POCT devices under CLIA, with tests categorized by complexity. Waived tests are simple and low-risk, while moderate and high complexity tests require more oversight. The FDA 2025 guidance emphasizes the need for post-market surveillance to monitor real-world performance. The Clinical and Laboratory Standards Institute (CLSI) provides standards for POCT quality management, including operator training and proficiency testing. In the European Union, the In Vitro Diagnostic Regulation (IVDR) 2022 applies, requiring CE marking for all POCT devices.

How reliable are point-of-care tests?

The reliability of POCT varies by test and brand. According to the FDA 2025 report, most FDA-cleared POCT devices have accuracy rates above 90% compared to lab reference methods. However, some tests, like rapid flu tests, have lower sensitivity, meaning false negatives can occur. The CDC 2025 update notes that molecular POCT, such as PCR-based tests, offers higher accuracy than antigen tests. Users should always follow instructions and confirm results with a lab test if there is any doubt.

What are the common mistakes to avoid with point-of-care testing?

Common mistakes include using expired tests, not following storage instructions, performing tests incorrectly, and misinterpreting results. For example, using a glucose meter without coding it correctly can lead to inaccurate readings. The American Diabetes Association (ADA) 2025 guidelines emphasize the importance of proper technique and regular calibration. Additionally, patients should not use POCT to replace regular medical care; it is a complement, not a substitute.

How can you get started with point-of-care testing?

If you are a healthcare provider, start by identifying the tests that would benefit your patient population, then choose devices that are FDA-cleared and meet your needs. Training staff and implementing quality control are essential. If you are a patient, consult your provider about which POCT you can use at home, and ensure you receive proper instruction. Many pharmacies and clinics offer POCT services, and telehealth platforms can connect you with providers who can order and interpret tests.

Conclusion

Point-of-care testing has transformed healthcare by providing rapid, accessible, and actionable diagnostic information. From improving patient outcomes to expanding access in underserved areas, POCT is a critical component of modern medicine. While challenges such as accuracy and cost remain, ongoing technological advancements and regulatory oversight are enhancing its reliability. As we move into 2026, POCT is poised to become even more integrated into everyday care, empowering patients and providers alike.

Now that you understand the basics of point-of-care testing, explore our related articles on home health monitoring and telehealth services to learn more about how you can take charge of your health.